Evaluation of an Incentive-based Intervention to Improve 90-day Adherence in PAP-Naive Patients

Not Applicable

Completed

Brief Summary: This is a prospective, randomized, open-label study to evaluate effectiveness of applying financial and social incentives via a smartphone-based app in helping participants achieve adherence to PAP therapy.

Detailed Description: This is a prospective, randomized, two-arm, open-label study to evaluate effectiveness of applying financial and social incentives via a smartphone-based app in helping participants achieve adherence to therapy. Randomization will include an allocation ratio of 2:1 (control:treatment).

Participants will be recruited based on evidence that they are struggling to achieve adherence to therapy after the first 3 nights of usage. Two 'site to participant' contacts are required during this study. These contacts can either occur at the clinical site or remotely (e.g., by telephone). During the initial contact, their interest in the study and eligibility will be confirmed, then they will be consented, asked to complete the Baseline Questionnaire, and their demographic information will be collected on case report forms (CRFs).

Participants randomized to the intervention (Group B) will be provided with information and assistance in downloading Restful to their smartphone and registering with Wellth.

At the final contact (90 days), the participant will be asked to complete an End of Study Questionnaire and the investigative staff will collect PAP therapy data for the trial period and record it on CRFs. Participants in Group B will have access to the Restful app discontinued. This completes the participant's active participation in the study.

Recruitment & Eligibility

Inclusion Criteria

Exclusion Criteria

Have used PAP therapy in the past
Have been prescribed bi-level or adaptive servo-ventilation therapy
Are participating in another app-based research study
Cannot participate for the full duration of the study (at least 90 days)
Participants who have a medical history or concurrent illness that the investigator considers sufficiently serious to interfere with the conduct, completion, or results of this study, or constitutes an unacceptable risk to the participant for the duration of the study

Arm && Interventions

Group	Intervention	Description
Wellth App (Group B)	Wellth app	Intervention is use of the Wellth app during the initial compliance period.

Primary Outcome Measures

Name	Time	Method
Mean PAP Usage at 90 Days	90 days	Average nightly CPAP use for the 90 day time frame.

Secondary Outcome Measures

Name	Time	Method
Change in FOSQ-10 Questionnaire Scores	90 days	Functional Outcomes of Sleep Questionnaire (FOSQ-10) will be administered at baseline and 90 days. The unit for this outcome is points. The range of scores is 5 to 20. Higher scores indicate better functional status. A larger change or change that decreases from baseline will represent a better outcome. A smaller change or change that increases from baseline will represent a worse outcome.
% of Participants That Meet Medicare Compliance Standard	90 days	Medicare compliance standard is using the PAP therapy for at least 4 hours per day on at least 70% of the days in a consecutive 30-day period any time in the first 90 days of therapy. Those that meet this standard are counted in the results below and divided by all patients.
Change in ESS Questionnaire Scores	90 days	Epworth Sleepiness Scale (ESS) will be administered at baseline and 90 days. The unit for this outcome is points. The total score can range from 0 to 24. A larger change or change that decreases from baseline will represent a better outcome. A smaller change or change that increases from baseline will represent a worse outcome. A higher score indicates worse symptoms.